P David Bonita

Affiliations

  • at Prelude Therapeutics Inc (PRLD), 2025-06-13
  • at Repare Therapeutics Inc. (RPTX), 2024-06-20
  • at Third Harmonic Bio Inc. (THRD), 2024-06-10
  • at Ikena Oncology Inc. (IKNA), 2024-06-10
  • Director at Acutus Medical Inc. (AFIB), 2023-06-15
  • Large Shareholder, Director at Tricida Inc. (TCDA), 2022-11-26
  • Large Shareholder, Director at Imara Inc. (IMRA), 2022-06-04
  • Director at Si-Bone Inc. (SIBN), 2018-10-19
  • Large Shareholder, Director at Viewray Inc. (VRAY), 2018-04-25
  • Director at Loxo Oncology Inc. (LOXO), 2017-12-12
  • Director at Ambit Biosciences Corp (AMBI), 2014-05-16
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PRLD $5.75 869,565 $4,999,998.75 10,119,756 2023-05-22 Filing
THRD $17.00 300,000 $5,100,000.00 5,779,071 2022-09-19 Filing
IKNA $5.37 96,035 $515,707.95 2,098,097 2022-06-24 Filing
IKNA $4.37 65,965 $288,267.05 2,002,062 2022-06-24 Filing
IKNA $3.71 23,419 $86,884.49 1,936,097 2022-06-23 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TCDA $0.22 3,629,226 $798,429.72 0 2022-11-25 Filing
TCDA $0.21 5,617,300 $1,179,633.00 3,629,226 2022-11-23 Filing
TCDA $0.22 1,034,421 $227,572.62 9,246,526 2022-11-22 Filing
RPTX $33.93 26 $882.18 96,190 2021-09-07 Filing
RPTX $33.93 861 $29,213.73 3,177,041 2021-09-07 Filing